Can-Fite BioPharma
22
3
3
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 30/100
13.6%
3 terminated/withdrawn out of 22 trials
82.4%
-4.2% vs industry average
23%
5 trials in Phase 3/4
79%
11 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome
Role: lead
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
Role: lead
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Role: lead
Namodenoson Treatment of Advanced Pancreatic Cancer
Role: lead
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Role: lead
Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Role: lead
Safety and Efficacy Study of CF101 to Treat Psoriasis
Role: lead
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Role: lead
Trial of CF101 to Treat Patients With Dry Eye Disease
Role: lead
CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
Role: lead
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Role: lead
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma
Role: lead
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
Role: lead
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
Role: lead
Piclidenoson for Treatment of COVID-19
Role: lead
CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis
Role: lead
Trial of CF101 to Treat Patients With Psoriasis
Role: lead
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
Role: lead
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
Role: lead
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
Role: lead